HOLMDEL, N.J. and OELDE, Germany, Jan. 17, 2024 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring Identity-Bound Biometric (IBB) authentication solutions, today announced that Haver & Boecker, a global leader in processing and packaging technology for bulk materials, has implemented Multifactor Authentication (MFA) and Single Sign-On (SSO) technology for its digital platforms via P&W Netzw ...

FORM 10-Q For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT Commission file number 1-13463 DELAWARE 41-1741861 (State or Other Jurisdiction of Incorporation of Organization) (IRS Employer Identification Number) (Address of Principal Executive Offices) Securities registered pursuance to Section 12(b) of the Act: Common Stock, par value $0.0001 per share BKYI Nasdaq Capital Market Indicate by check mark whether the registrant has submitted e ...

FORM 10-Q Commission file number 1-13463 (732) 359-1100 (Registrant's telephone number, including area code) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ If an emerging growth company, indicate by chec ...

BIO-key International, Inc. (NASDAQ:BKYI) Q2 2023 Earnings Conference Call August 15, 2023 10:00 AM ET Bill Jones – Investor Relations Conference Call Participants Good morning, everyone. Thank you for standing by, and welcome to BIO-key International Second Quarter 2023 Conference Call. During managementÂ's prepared remarks all participants will be in listen-only mode. [Operator Instructions] As a reminder, this conference is being recorded today, Tuesday, August 15, 2023. Thank you, everyone, for joining ...

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT 3349 HIGHWAY 138, BUILDING A, SUITE E, WALL, NJ 07719 (Address of Principal Executive Offices) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ ...

● International law enforcement use case applications as prospects see us as a global leader in the biometric technology space as witnessed by our agreement with the Israeli Defense Force, and the Singapore and Dubai Police departments. 4 We sell our products directly through our field and inside sales teams, as well as indirectly through our network of channel partners. Through our Channel Alliance Program, we have partnered with more than 40 resellers, system integrators and other distribution partners. W ...

BIO-key International, Inc. (NASDAQ:BKYI) Q1 2023 Results Conference Call May 16, 2023 10:00 AM ET Company Participants William Jones - Catalyst IR Michael DePasquale - Chairman and CEO Cecilia Welch - CFO Conference Call Participants Jack Vander Aarde - Maxim Group Operator Good morning, everyone. Thank you for standing by, and welcome to the BIO-key International's First Quarter 2023 Conference Call. [Operator Instructions]. As a reminder, this conference call is being recorded today, Tuesday, May 16, 202 ...

BIO-key International, Inc. (NASDAQ:BKYI) Q4 2022 Earnings Conference Call March 31, 2023 10:00 AM ET Company Participants Michael DePasquale - Chairman and CEO Cecilia Welch - CFO Jack Vander Aarde - Maxim Group Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the BIO-key International Fourth Quarter Conference Call. During management's prepared remarks, all participants will be in a listen-only mode. Afterwards, listeners will be invited to participate in a question-and-answer ...

BIO-key International, Inc. (NASDAQ:BKYI) Q3 2022 Earnings Conference Call November 15, 2022 10:00 AM ET Company Participants Kimberly Johnson - Vice President, Product Michael DePasquale - Chairman and CEO Alex Rocha - Managing Director Cecilia Welch - CFO Conference Call Participants Operator Good morning, ladies and gentlemen. Thank you for standing by, and welcome to the BIO-key International Third Quarter Conference Call. During management's prepared remarks, all participants will be in a listen-only m ...

U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE EXCHANGE ACT For the Transition Period from to Commission file number 1-13463 BIO-KEY INTERNATIONAL, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 41-1741861 (State or Other Jurisdiction of Incorporation of Organization) (IRS ...